Surrogacy market seen reaching $78.68B by 2031

Mordor Intelligence says the global surrogacy market will nearly triple from 2026 to 2031, powered by infertility trends, delayed parenthood and wider use of IVF. North America leads now, while Asia-Pacific is expected to grow fastest as cross-border arrangements and fertility tourism expand.

Why it matters: - The surrogacy market is projected to grow from USD 28.91 billion in 2026 to USD 78.68 billion by 2031, signaling stronger demand for assisted reproduction services. - The forecast points to rising infertility, later parenthood and broader acceptance of diverse family structures as major drivers of fertility care demand. - IVF advances, AI-assisted embryo selection and employer-funded fertility benefits are making treatment more accessible and more data-driven.

What happened: - Mordor Intelligence projected a 22.19% CAGR for the global surrogacy market from 2026 to 2031. - North America accounted for 40.78% of global revenue in 2025 and remained the largest regional market. - Asia-Pacific was projected to be the fastest-growing region, with a 22.92% CAGR during 2026–2031.

The details: - IVF represented 66.12% of the surrogacy market in 2025, reflecting its central role in gestational surrogacy. - Fertility providers are adopting AI-assisted embryo selection, genetic testing, time-lapse imaging and laboratory automation. - Cross-border surrogacy is expanding as intended parents weigh costs, treatment availability, healthcare infrastructure and legal frameworks. - Mordor Intelligence said cross-border arrangements are expected to grow faster than domestic arrangements through 2031. - Regulatory changes and shifting parentage rules continue to shape domestic and international surrogacy flows. - North America benefits from established fertility infrastructure and expanding employer-sponsored fertility benefits. - The United States remains an important surrogacy destination, while Canada operates under an altruistic framework. - Europe has widely varying commercial and altruistic surrogacy rules across countries. - Asia-Pacific growth is being supported by fertility infrastructure expansion, greater use of assisted reproductive technologies and changing regulations in India, Thailand, China, Japan and Australia.

Between the lines: - The market forecast suggests surrogacy is becoming more formalized and technology-intensive, with clinics and agencies competing on IVF capabilities, legal coordination and patient support. - Regulatory complexity remains a major constraint, especially for cross-border arrangements where parentage recognition and birth registration can affect where intended parents seek care. - The growth of employer fertility benefits signals that some of the cost burden is shifting away from patients, which could widen access in certain markets. - The report's emphasis on AI and genetic testing points to a broader move toward precision-driven fertility treatment, even as evidence standards and clinic disclosures stay under scrutiny.

What's next: - Market participants are likely to keep investing in IVF capacity, screening processes, transparent pricing and cross-border patient services. - Regulatory changes across major fertility markets will remain a key factor shaping domestic and international surrogacy demand. - Asia-Pacific's rapid growth could intensify competition among fertility centers, surrogacy agencies and hospitals in the region. - Mordor Intelligence also published related forecasts for IVF, assisted reproductive technology and fertility services markets, indicating continued expansion across the fertility sector.

The bottom line: - Surrogacy is moving from a niche service into a larger, more regulated fertility market, with IVF innovation and cross-border demand driving the next phase of growth. - The report is available in multiple languages, including Japanese, French, German, Spanish and Portuguese.